Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sitruk-Ware

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Contraception|September 1, 1989
Risk factors for breast fibroadenoma in young womenR Sitruk-Ware, J C Thalabard, A Benotmane, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1977
Inadequate corpus luteal function in women with benign breast diseasesL R Sitruk-ware, N Sterkers, I Mowszowicz, et al.
Maturitas|October 1, 1980
Absorption of percutaneous oestradiol in postmenopausal womenR Sitruk-Ware, B de Lignieres, A Basdevant, et al.
Journal of Reproduction and Fertility. Supplement|January 1, 1989
Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in womenI M Spitz, D Shoupe, R Sitruk-Ware, et al.
Presse Medicale (Paris, France : 1983)|March 3, 1984
[Gonadoliberin. Therapeutic prospects]R Sitruk-Ware, Y Le Bouc, A Gompel, et al.
Zentralblatt Fur Gynakologie|January 1, 1986
[Endocrine markers in benign breast diseases]J C Thalabard, R Sitruk-Ware, F Kuttenn, et al.
Contraception|December 1, 1985
Breast cancer and oral contraceptives: a reviewF Clavel, E Benhamou, R Sitruk-Ware, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 1, 1987
Prolactin secretion in benign breast diseasesR Sitruk-Ware, F Clair, N Sterkers, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 12, 1998
Progestins and breast cancerJ R Pasqualini, J Paris, R Sitruk-Ware, et al.
Contraception|October 1, 1987
Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a reviewR Sitruk-Ware, C Bricaire, B De Lignieres, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Contraception|September 1, 1989
Risk factors for breast fibroadenoma in young womenR Sitruk-Ware, J C Thalabard, A Benotmane, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1977
Inadequate corpus luteal function in women with benign breast diseasesL R Sitruk-ware, N Sterkers, I Mowszowicz, et al.
Maturitas|October 1, 1980
Absorption of percutaneous oestradiol in postmenopausal womenR Sitruk-Ware, B de Lignieres, A Basdevant, et al.
Journal of Reproduction and Fertility. Supplement|January 1, 1989
Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in womenI M Spitz, D Shoupe, R Sitruk-Ware, et al.
Presse Medicale (Paris, France : 1983)|March 3, 1984
[Gonadoliberin. Therapeutic prospects]R Sitruk-Ware, Y Le Bouc, A Gompel, et al.
Zentralblatt Fur Gynakologie|January 1, 1986
[Endocrine markers in benign breast diseases]J C Thalabard, R Sitruk-Ware, F Kuttenn, et al.
Contraception|December 1, 1985
Breast cancer and oral contraceptives: a reviewF Clavel, E Benhamou, R Sitruk-Ware, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 1, 1987
Prolactin secretion in benign breast diseasesR Sitruk-Ware, F Clair, N Sterkers, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 12, 1998
Progestins and breast cancerJ R Pasqualini, J Paris, R Sitruk-Ware, et al.
Contraception|October 1, 1987
Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a reviewR Sitruk-Ware, C Bricaire, B De Lignieres, et al.
Pageof 6